Alzheimer’s Disease

Transcranial pulse stimulation for the treatment of Alzheimer’s disease

Impact of TREM2 deficiency on amyloid beta plaque growth

APOEε4 drives tau accumulation through Aβ-dependent and Aβ-independent pathways

All-in-one AAV vector for epigenome editing shows efficient APOE downregulation in vivo

How do microglia digest large amyloid beta aggregates?

Boosting neurogenesis with NA-831: Phase III trial update

Benefits of an all-in-one AAV CRISPR/Cas9 system for genome/epigenome editing

Prioritizing research on neuromodulatory subcortical systems for new insights in Alzheimer’s disease

Random forests in large-scale omics studies

Assessing clinical meaningfulness with ‘time saved’ in Alzheimer’s disease

Boosting lysosomal function in microglia to treat Alzheimer’s disease

How does TPS work in Alzheimer’s disease?

Potential role of microglia in amyloid plaque formation and spread

Novel genome editing approaches under investigation in Alzheimer’s disease

Potential clinical meaningfulness of donanemab data

A call to review the CMS national coverage determination of anti-amyloid antibodies